Diabetes mortality during the COVID-19 pandemic in Mexico: an inequality-based approach
Authors:
- Oswaldo MedinaOMOswaldo Medina
- Jorge Escobedo de la PeñaJPJorge Escobedo de la Peña
Preprint
- 2 May 2025
- preprint
- Published by Springer Nature in Research Square
Abstract
Purpose.The aim of this study was to estimate inequalities in mortality from diabetes mellitus according to their sociodemographic characteristics, conditions of social marginalization, and medical care. Methods. An ecological study was conducted to estimate the slope index of inequality and the index of concentration of mortality inequality based on the marginalization conditions of the habitual residence at the municipal level. This analysis considered the deaths registered during the period from 2019 to 2021 due to diabetes in Mexico. Results. Mortality from diabetes increased during the pandemic. Those with the least access to health services had 98 more deaths per 100,000 people compared to those who had the greatest access to health services (95% CI -98.39 to -47.86). There was a higher mortality in the most vulnerable groups. Conclusions. The COVID-19 pandemic primarily impacted socially vulnerable groups. Tackling the social determinants of health in disadvantaged populations will aid governments in managing health emergencies, promoting disease prevention, early detection, and timely treatment. Trial registration: not applicableKeywords
All Related Versions
This publication has 37 references indexed in Scilit:
- Risk Factors for COVID-19: Diabetes, Hypertension, and Obesity2021
- High prevalence of diabetes and other comorbidities in hospitalized patients with COVID-19 in Delhi, India, and their association with outcomesDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2021
- Patients with arterial hypertension and COVID-19 are at higher risk of ICU admissionBritish Journal of Anaesthesia, 2020
- Obesity is Associated with Severe Forms of COVID‐19Obesity, 2020
- Socioeconomic inequalities and type 2 diabetes complications: A systematic reviewDiabetes & Metabolism, 2020
- Diabetes is a risk factor for the progression and prognosis of COVID‐19Diabetes/Metabolism Research and Reviews, 2020
- Association of artificially sweetened and sugar-sweetened soft drinks with β-cell function, insulin sensitivity, and type 2 diabetes: the Maastricht StudyEuropean Journal of Nutrition, 2019
- Association between sugar-sweetened and artificially sweetened soft drinks and type 2 diabetes: systematic review and dose–response meta-analysis of prospective studiesBritish Journal of Nutrition, 2014
- Epidemiology of Type 2 Diabetes in MexicoArchives of Medical Research, 2005
- On the measurement of inequalities in healthSocial Science & Medicine, 1991